Works by Diaz-Beya, Marina


Results: 41
    1

    CAR-T cell therapy for cancer: current challenges and future directions.

    Published in:
    Signal Transduction & Targeted Therapy, 2025, v. 10, n. 1, p. 1, doi. 10.1038/s41392-025-02269-w
    By:
    • Zugasti, Inés;
    • Espinosa-Aroca, Lady;
    • Fidyt, Klaudyna;
    • Mulens-Arias, Vladimir;
    • Diaz-Beya, Marina;
    • Juan, Manel;
    • Urbano-Ispizua, Álvaro;
    • Esteve, Jordi;
    • Velasco-Hernandez, Talia;
    • Menéndez, Pablo
    Publication type:
    Article
    2

    Results of ARI‐0001 CART19 cell therapy in patients with relapsed/refractory CD19‐positive acute lymphoblastic leukemia with isolated extramedullary disease.

    Published in:
    American Journal of Hematology, 2022, v. 97, n. 6, p. 731, doi. 10.1002/ajh.26519
    By:
    • Ortiz‐Maldonado, Valentín;
    • Alonso‐Saladrigues, Anna;
    • Español‐Rego, Marta;
    • Martínez‐Cibrián, Nuria;
    • Faura, Anna;
    • Magnano, Laura;
    • Català, Albert;
    • Benítez‐Ribas, Daniel;
    • Giné, Eva;
    • Díaz‐Beyá, Marina;
    • Correa, Juan Gonzalo;
    • Rovira, Montserrat;
    • Montoro‐Lorite, Mercedes;
    • Martínez‐Roca, Alexandra;
    • Rodríguez‐Lobato, Luis Gerardo;
    • Cabezón, Raquel;
    • Cid, Joan;
    • Lozano, Miquel;
    • Garcia‐Rey, Enric;
    • Conde, Nuria
    Publication type:
    Article
    3

    Genetic evolution and relapse‐associated mutations in adult T‐cell acute lymphoblastic leukemia patients treated in PETHEMA trials.

    Published in:
    HemaSphere, 2025, v. 9, n. 5, p. 1, doi. 10.1002/hem3.70148
    By:
    • González‐Gil, Celia;
    • Lopes, Thaysa;
    • Morgades, Mireia;
    • Fuster‐Tormo, Francisco;
    • Montesinos, Pau;
    • Medina, Carlos Rodríguez;
    • Hermosín, Lourdes;
    • González‐Martínez, Teresa;
    • Queipo, María‐Paz;
    • González‐Campos, José;
    • Martínez‐Sánchez, Pilar;
    • Díaz‐Beya, Marina;
    • Coll, Rosa;
    • Maluquer, Clara;
    • Zamora, Lurdes;
    • Artola, Teresa;
    • Vall‐Llovera, Ferran;
    • Tormo, Mar;
    • Torrent, Anna;
    • Martínez‐Laperche, Carolina
    Publication type:
    Article
    4

    Machine Learning Improves Risk Stratification in Myelodysplastic Neoplasms: An Analysis of the Spanish Group of Myelodysplastic Syndromes.

    Published in:
    HemaSphere, 2023, v. 7, n. 10, p. e961, doi. 10.1097/HS9.0000000000000961
    By:
    • Mosquera Orgueira, Adrian;
    • Perez Encinas, Manuel Mateo;
    • Diaz Varela, Nicolas A;
    • Mora, Elvira;
    • Díaz‐Beyá, Marina;
    • Montoro, María Julia;
    • Pomares, Helena;
    • Ramos, Fernando;
    • Tormo, Mar;
    • Jerez, Andres;
    • Nomdedeu, Josep F;
    • De Miguel Sanchez, Carlos;
    • Leonor, Arenillas;
    • Cárcel, Paula;
    • Cedena Romero, Maria Teresa;
    • Xicoy, Blanca;
    • Rivero, Eugenia;
    • del Orbe Barreto, Rafael Andres;
    • Diez‐Campelo, Maria;
    • Benlloch, Luis E.
    Publication type:
    Article
    5

    PB1846: MANAGEMENT OF PATIENTS TREATED WITH VENETOCLAX WITH HYPOMETHYLATING AGENTS: LONG‐TERM INCIDENCE OF CYTOPENIAS AND INFECTIONS.

    Published in:
    HemaSphere, 2023, v. 7, p. 1, doi. 10.1097/01.HS9.0000974224.32922.f1
    By:
    • Guardia‐Torrelles, Ares;
    • Jimenez‐Vicente, Carlos;
    • Roca, Alexandra Martínez;
    • Castaño‐Díez, Sandra;
    • Brillembourg, Helena;
    • Guijarro, Francesca;
    • Bataller, Àlex;
    • Esteban, Daniel;
    • Cortés, Albert;
    • Zugasti, Inés;
    • Munarriz, Daniel;
    • Diaz‐Beya, Marina;
    • Esteve, Jordi;
    • Merchan, Beatriz
    Publication type:
    Article
    6
    7

    P703: THE AIPSS‐MDS MACHINE LEARNING MODEL PREDICTS OVERALL SURVIVAL AND LEUKEMIC TRANSFORMATION IN CMML: AN ANALYSIS OF THE SPANISH REGISTRY OF MDS.

    Published in:
    HemaSphere, 2023, v. 7, p. 1, doi. 10.1097/01.HS9.0000969716.69250.c9
    By:
    • Mosquera‐Orgueira, Adrian;
    • Mateo Perez Encinas, Manuel;
    • Diaz Varela, Nicolas;
    • Wang, Yu‐Hung;
    • Mora, Elvira;
    • Diaz‐Beya, Marina;
    • Julia Montoro, Maria;
    • Pomares Marin, Helena;
    • Ramos Ortega, Fernando;
    • Tormo, Mar;
    • Jerez, Andres;
    • Nomdedeu, Josep;
    • de Migue Sanchez, Carlos;
    • Arenillas, Leonor;
    • Carcel, Paula;
    • Teresa Cedena Romero, Maria;
    • Xicoy Cirici, Blanca;
    • Rivero Arango, Eugenia;
    • Andrés Del Orbe Barreto, Rafael;
    • Benlloch, Luis
    Publication type:
    Article
    8

    P531: MIDOSTAURIN PLUS 7 + 3 OR QUIZARTINIB PLUS 7 + 3 IN FLT3‐ITD MUTATED AML.

    Published in:
    HemaSphere, 2023, v. 7, p. 1, doi. 10.1097/01.HS9.0000969032.40255.74
    By:
    • Tormo, Mar;
    • Diaz‐Beya, Marina;
    • Beneit, Paola;
    • Fernández Moreno, Ainhoa;
    • Arnan, Montserrat;
    • Garrido Diaz, Ana;
    • Vives, Susana;
    • García Fortes, Maria;
    • Sampol, Antonia;
    • Labrador, Jorge;
    • Garcia‐Guiñon, Antonio;
    • Botella, Carmen;
    • Miguel Bergua Burgues, Juan;
    • Olave, Mayte;
    • Luz Amigo, Maria;
    • Ortín, Xavier;
    • Ferran Vall‐Llovera, Ferrand;
    • Pereiro, Maria;
    • Serrano, Josefina;
    • Jose Sayas Lloris, Maria
    Publication type:
    Article
    9
    10

    Chronic myelomonocytic leukemia with ring sideroblasts/SF3B1 mutation presents with low monocyte count and resembles myelodysplastic syndromes with-RS/SF3B1 mutation in terms of phenotype and prognosis.

    Published in:
    Frontiers in Oncology, 2024, p. 1, doi. 10.3389/fonc.2024.1385987
    By:
    • Xicoy, Blanca;
    • Pomares, Helena;
    • Morgades, Mireia;
    • Germing, Ulrich;
    • Arnan, Montserrat;
    • Tormo, Mar;
    • Palomo, Laura;
    • Orna, Elisa;
    • Porta, Matteo Della;
    • Schulz, Felicitas;
    • Díaz-Beya, Marina;
    • Esteban, Ada;
    • Molero, Antonieta;
    • Lanino, Luca;
    • Avendaño, Alejandro;
    • Hernández, Francisca;
    • Roldan, Verónica;
    • Ubezio, Marta;
    • Pineda, Alberto;
    • Dfez-Campelo, María
    Publication type:
    Article
    11

    A novel ETV6::FGFR1 fusion gene in a myeloid/lymphoid neoplasm with FGFR1 rearrangement sensitive to specific FGFR1-2-3 inhibition.

    Published in:
    Leukemia & Lymphoma, 2024, v. 65, n. 3, p. 394, doi. 10.1080/10428194.2023.2295788
    By:
    • Jiménez-Vicente, Carlos;
    • Garrote, Marta;
    • López-Guerra, Mónica;
    • Villamón, Eva;
    • Guijarro, Francesca;
    • Perez-Valencia, Amanda Isabel;
    • Martinez-Roca, Alexandra;
    • Balaguer, Olga;
    • Álvarez-Larrán, Alberto;
    • Hernández-Boluda, Juan Carlos;
    • Rovira, Montserrat;
    • Colomer, Dolors;
    • Diaz-Beyá, Marina;
    • Rozman, Maria;
    • Esteve, Jordi
    Publication type:
    Article
    12
    13

    Bone marrow VEGFC expression is associated with multilineage dysplasia and several prognostic markers in adult acute myeloid leukemia, but not with survival.

    Published in:
    Leukemia & Lymphoma, 2018, v. 59, n. 10, p. 2383, doi. 10.1080/10428194.2017.1422858
    By:
    • Guillem, Vicent;
    • Calabuig, Marisa;
    • Brunet, Salut;
    • Esteve, Jordi;
    • Escoda, Lourdes;
    • Gallardo, David;
    • Ribera, Josep-Maria;
    • Queipo de Llano, María Paz;
    • Arnan, Montserrat;
    • Pedro, Carme;
    • Amigo, María Luz;
    • Martí-Tutusaus, Josep M.;
    • García-Guiñón, Antoni;
    • Bargay, Joan;
    • Sampol, Antonia;
    • Salamero, Olga;
    • Font, Llorenç;
    • Talarn, Carme;
    • Hoyos, Montserrat;
    • Díaz-Beyá, Marina
    Publication type:
    Article
    14

    Whole Exome Sequencing of Intermediate-Risk Acute Myeloid Leukemia without Recurrent Genetic Abnormalities Offers Deeper Insights into New Diagnostic Classifications.

    Published in:
    International Journal of Molecular Sciences, 2024, v. 25, n. 16, p. 8669, doi. 10.3390/ijms25168669
    By:
    • Guijarro, Francesca;
    • Castaño-Díez, Sandra;
    • Jiménez-Vicente, Carlos;
    • Garrote, Marta;
    • Álamo, José Ramón;
    • Gómez-Hernando, Marta;
    • López-Oreja, Irene;
    • Morata, Jordi;
    • López-Guerra, Mònica;
    • López, Cristina;
    • Beà, Sílvia;
    • Costa, Dolors;
    • Colomer, Dolors;
    • Díaz-Beyá, Marina;
    • Rozman, Maria;
    • Esteve, Jordi
    Publication type:
    Article
    15
    16
    17

    Outcomes and prognostic factors of adults with refractory or relapsed T‐cell acute lymphoblastic leukemia included in measurable residual disease‐oriented trials.

    Published in:
    Hematological Oncology, 2021, v. 39, n. 4, p. 529, doi. 10.1002/hon.2910
    By:
    • Ribera, Josep‐Maria;
    • Morgades, Mireia;
    • Genescà, Eulàlia;
    • Chapchap, Eduardo‐Cerello;
    • Montesinos, Pau;
    • Acuña‐Cruz, Evelyn;
    • Gil, Cristina;
    • García‐Cadenas, Irene;
    • Barba, Pere;
    • González‐Campos, José;
    • Queipo de Llano, María‐Paz;
    • Torrent, Anna;
    • Ribera, Jordi;
    • Granada, Isabel;
    • Bernal, Teresa;
    • Díaz‐Beyá, Marina;
    • Amigo, María‐Luz;
    • Coll, Rosa;
    • Tormo, Mar;
    • Vall‐llovera, Ferran
    Publication type:
    Article
    18
    19

    Clinical management of patients diagnosed with acute myeloid leukemia treated with venetoclax in combination with hypomethylating agents after achieving a response: a real-life study.

    Published in:
    Annals of Hematology, 2024, v. 103, n. 10, p. 4033, doi. 10.1007/s00277-024-05923-5
    By:
    • Jiménez-Vicente, Carlos;
    • Guardia-Torrelles, Ares;
    • Pérez-Valencia, Amanda Isabel;
    • Martínez-Roca, Alexandra;
    • Castaño-Diez, Sandra;
    • Guijarro, Francesca;
    • Cortés-Bullich, Albert;
    • Merchán, Beatriz;
    • Triguero, Ana;
    • Hernández, Isabel;
    • Brillembourg, Helena;
    • Munárriz, Daniel;
    • Zugasti, Inés;
    • Fernández-Avilés, Francesc;
    • Diaz-Beyá, Marina;
    • Esteve, Jordi
    Publication type:
    Article
    20

    Correction to: A phase I-II study of plerixafor in combination with fludarabine, idarubicin, cytarabine, and G-CSF (PLERIFLAG regimen) for the treatment of patients with the first early-relapsed or refractory acute myeloid leukemia.

    Published in:
    2018
    By:
    • on behalf of the CETLAM and PETHEMA groups;
    • CETLAM and PETHEMA groups;
    • Boluda, Blanca;
    • Rodríguez-Veiga, Rebeca;
    • Moscardó, Federico;
    • Martínez-Cuadrón, David;
    • Cordón, Lourdes;
    • Sempere, Amparo;
    • Montesinos, Pau;
    • Sanz, Miguel A.;
    • Garrido, Ana;
    • Benavente, Celina;
    • Pérez-Simón, José Antonio;
    • Martínez, Pilar;
    • Jiménez-Ubieto, Ana;
    • Bergua, Juan;
    • Prieto-Delgado, Julio;
    • Esteve, Jordi;
    • Díaz-Beyá, Marina;
    • Vives, Susana
    Publication type:
    journal article
    21

    A phase I-II study of plerixafor in combination with fludarabine, idarubicin, cytarabine, and G-CSF (PLERIFLAG regimen) for the treatment of patients with the first early-relapsed or refractory acute myeloid leukemia.

    Published in:
    2018
    By:
    • on behalf of the CETLAM and PETHEMA groups;
    • CETLAM and PETHEMA groups;
    • Boluda, Blanca;
    • Rodríguez-Veiga, Rebeca;
    • Moscardó, Federico;
    • Martínez-Cuadrón, David;
    • Cordón, Lourdes;
    • Sempere, Amparo;
    • Montesinos, Pau;
    • Sanz, Miguel A.;
    • Garrido, Ana;
    • Benavente, Celina;
    • Pérez-Simón, José Antonio;
    • Martínez, Pilar;
    • Jiménez-Ubieto, Ana;
    • Bergua, Juan;
    • Prieto-Delgado, Julio;
    • Esteve, Jordi;
    • Díaz-Beyá, Marina;
    • Vives, Susana
    Publication type:
    journal article
    22

    Multilineage dysplasia is associated with a poorer prognosis in patients with de novo acute myeloid leukemia with intermediate-risk cytogenetics and wild-type NPM1.

    Published in:
    Annals of Hematology, 2014, v. 93, n. 10, p. 1695, doi. 10.1007/s00277-014-2100-6
    By:
    • Rozman, María;
    • Navarro, José-Tomás;
    • Arenillas, Leonor;
    • Aventín, Anna;
    • Giménez, Teresa;
    • Alonso, Esther;
    • Perea, Granada;
    • Camós, Mireia;
    • Navarrete, Mayda;
    • Tuset, Esperanza;
    • Florensa, Lourdes;
    • Millá, Fuensanta;
    • Nomdedéu, Josep;
    • Banda, Esmeralda;
    • Díaz-Beyá, Marina;
    • Pratcorona, Marta;
    • Garrido, Ana;
    • Navarro, Blanca;
    • Brunet, Salut;
    • Sierra, Jorge
    Publication type:
    Article
    23

    Serotonin receptor type 1B constitutes a therapeutic target for MDS and CMML.

    Published in:
    Scientific Reports, 2018, v. 8, n. 1, p. 1, doi. 10.1038/s41598-018-32306-4
    By:
    • Banús-Mulet, Antònia;
    • Etxabe, Amaia;
    • Cornet-Masana, Josep Maria;
    • Torrente, Miguel Ángel;
    • Lara-Castillo, María Carmen;
    • Palomo, Laura;
    • Nomdedeu, Meritxell;
    • Díaz-Beyá, Marina;
    • Solé, Francesc;
    • Nomdedeu, Benet;
    • Esteve, Jordi;
    • Risueño, Ruth M.
    Publication type:
    Article
    24
    25

    At-Home Care Program for Acute Myeloid Leukemia Induction Phase in Patients Treated with Venetoclax-Based Low-Intensity Regimens.

    Published in:
    Cancers, 2024, v. 16, n. 24, p. 4274, doi. 10.3390/cancers16244274
    By:
    • Martínez-Roca, Alexandra;
    • Jiménez-Vicente, Carlos;
    • Merchán, Beatriz;
    • Castaño-Diez, Sandra;
    • Zugasti, Inés;
    • Brillembourg, Helena;
    • Bataller, Álex;
    • Guijarro, Francesca;
    • Cortés-Bullich, Albert;
    • Trigueros, Ana;
    • Pérez-Valencia, Amanda Isabel;
    • Gallego, Cristina;
    • Ballestar, Nuria;
    • Rodríguez-Lobato, Luis Gerardo;
    • Carcelero, Esther;
    • Díaz-Beyá, Marina;
    • Esteve, Jordi;
    • Fernández-Avilés, Francesc
    Publication type:
    Article
    26

    Salvage Therapy with Second-Generation Inhibitors for FLT3 Mutated Acute Myeloid Leukemia: A Real-World Study by the CETLAM and PETHEMA Groups.

    Published in:
    Cancers, 2024, v. 16, n. 23, p. 4028, doi. 10.3390/cancers16234028
    By:
    • Vives, Susana;
    • Quintela, David;
    • Morgades, Mireia;
    • Cano-Ferri, Isabel;
    • Serrano, Alfons;
    • Acuña-Cruz, Evelyn;
    • Cervera, Marta;
    • Díaz-Beyá, Marina;
    • Vidriales, Belén;
    • Raposo-Puglia, José Ángel;
    • Arnan, Montserrat;
    • Garrido, Ana;
    • Balerdi, Amaia;
    • Cabello, Ana Isabel;
    • Herrera-Puente, Pilar;
    • Serrano, Josefina;
    • Coll, Rosa;
    • Tormo, Mar;
    • López-Marín, Javier;
    • García-Ávila, Sara
    Publication type:
    Article
    27
    28
    29

    Real-World Data on Chronic Myelomonocytic Leukemia: Clinical and Molecular Characteristics, Treatment, Emerging Drugs, and Patient Outcomes.

    Published in:
    Cancers, 2022, v. 14, n. 17, p. 4107, doi. 10.3390/cancers14174107
    By:
    • Castaño-Díez, Sandra;
    • López-Guerra, Mónica;
    • Bosch-Castañeda, Cristina;
    • Bataller, Alex;
    • Charry, Paola;
    • Esteban, Daniel;
    • Guijarro, Francesca;
    • Jiménez-Vicente, Carlos;
    • Castillo-Girón, Carlos;
    • Cortes, Albert;
    • Martínez-Roca, Alexandra;
    • Triguero, Ana;
    • Álamo, José Ramón;
    • Beà, Silvia;
    • Costa, Dolors;
    • Colomer, Dolors;
    • Rozman, María;
    • Esteve, Jordi;
    • Díaz-Beyá, Marina
    Publication type:
    Article
    30
    31

    Evaluation of European LeukemiaNet 2022 risk classification in patients undergoing allogeneic haematopoietic stem cell transplantation for acute myeloid leukaemia: Identification of a very poor prognosis genetic group.

    Published in:
    British Journal of Haematology, 2024, v. 205, n. 1, p. 256, doi. 10.1111/bjh.19518
    By:
    • Jiménez‐Vicente, Carlos;
    • Charry, Paola;
    • Castaño‐Diez, Sandra;
    • Guijarro, Francesca;
    • López‐Guerra, Mònica;
    • Pérez‐Valencia, Amanda Isabel;
    • Martinez‐Roca, Alexandra;
    • Cortés‐Bullich, Albert;
    • Munárriz, Daniel;
    • Solano, Maria Teresa;
    • Rosiñol, Laura;
    • Carreras, Enric;
    • Urbano‐Ispizua, Álvaro;
    • Fernández‐Avilés, Francesc;
    • Martinez, Carmen;
    • Suárez‐Lledó, María;
    • Díaz‐Beyá, Marina;
    • Rovira, Montserrat;
    • Salas, María Queralt;
    • Esteve, Jordi
    Publication type:
    Article
    32

    Validation of the Artificial Intelligence Prognostic Scoring System for Myelodysplastic Syndromes in chronic myelomonocytic leukaemia: A novel approach for improved risk stratification.

    Published in:
    British Journal of Haematology, 2024, v. 204, n. 4, p. 1529, doi. 10.1111/bjh.19341
    By:
    • Mosquera Orgueira, Adrian;
    • Perez Encinas, Manuel Mateo;
    • Diaz Varela, Nicolas;
    • Wang, Yu‐Hung;
    • Mora, Elvira;
    • Diaz‐Beya, Marina;
    • Montoro, Maria Julia;
    • Pomares Marin, Helena;
    • Ramos Ortega, Fernando;
    • Tormo, Mar;
    • Jerez, Andres;
    • Nomdedeu, Josep;
    • de Miguel Sanchez, Carlos;
    • Arenillas, Leonor;
    • Carcel, Paula;
    • Cedena Romero, Maria Teresa;
    • Xicoy Cirici, Blanca;
    • Rivero Arango, Eugenia;
    • Del Orbe Barreto, Rafael Andrés;
    • Benlloch, Luis
    Publication type:
    Article
    33

    Characteristics and long‐term outcome in a large series of chronic myelomonocytic leukaemia patients including 104 formerly referred to as oligomonocytic.

    Published in:
    British Journal of Haematology, 2024, v. 204, n. 3, p. 892, doi. 10.1111/bjh.19217
    By:
    • Castaño‐Díez, Sandra;
    • Pomares, Helena;
    • Esteban, Daniel;
    • Guijarro, Francesca;
    • Jiménez‐Vicente, Carlos;
    • Zugasti, Inés;
    • Álamo, José Ramón;
    • Mayayo, Víctor Torrecillas;
    • López‐Guerra, Mònica;
    • de la Fuente, Cristina;
    • Charry, Paola;
    • Cortés‐Bullich, Albert;
    • Bataller, Álex;
    • Maluquer, Clara;
    • Colomer, Dolors;
    • Rozman, María;
    • Arnan, Montserrat;
    • Xicoy, Blanca;
    • Esteve, Jordi;
    • Díaz‐Beyá, Marina
    Publication type:
    Article
    34

    Acute myeloid leukemia with NPM1 mutation and favorable European LeukemiaNet category: outcome after preemptive intervention based on measurable residual disease.

    Published in:
    British Journal of Haematology, 2020, v. 191, n. 1, p. 52, doi. 10.1111/bjh.16857
    By:
    • Bataller, Alex;
    • Oñate, Guadalupe;
    • Diaz‐Beyá, Marina;
    • Guijarro, Francesca;
    • Garrido, Ana;
    • Vives, Susana;
    • Tormo, Mar;
    • Arnan, Montserrat;
    • Salamero, Olga;
    • Sampol, Antònia;
    • Coll, Rosa;
    • Vall‐Llovera, Ferran;
    • Oliver‐Caldés, Aina;
    • López‐Guerra, Mònica;
    • Pratcorona, Marta;
    • Zamora, Lurdes;
    • Villamon, Eva;
    • Roué, Gaël;
    • Blanco, Adoración;
    • Nomdedeu, Josep F.
    Publication type:
    Article
    35

    Allogeneic stem cell transplantation in AML with t(6;9)(p23;q34);DEK‐NUP214 shows a favourable outcome when performed in first complete remission.

    Published in:
    British Journal of Haematology, 2020, v. 189, n. 5, p. 920, doi. 10.1111/bjh.16433
    By:
    • Díaz‐Beyá, Marina;
    • Labopin, Myriam;
    • Maertens, Johan;
    • Alijurf, Mahmoud;
    • Passweg, Jakob;
    • Dietrich, Beelen;
    • Schouten, Harry;
    • Socié, Gerard;
    • Schaap, Nicolaas;
    • Schwerdtfeger, Rainer;
    • Volin, Liisa;
    • Michallet, Mauricette;
    • Polge, Emmanuelle;
    • Sierra, Jorge;
    • Mohty, Mohamad;
    • Esteve, Jordi;
    • Nagler, Arnon
    Publication type:
    Article
    36
    37
    38

    Relevance of infections on the outcomes of patients with myelodysplastic syndromes, chronic myelomonocytic leukemia, and acute myeloid leukemia treated with hypomethylating agents: a cohort study from the GESMD.

    Published in:
    Therapeutic Advances in Hematology, 2022, v. 13, p. 1, doi. 10.1177/20406207221127547
    By:
    • Vilorio-Marqués, Laura;
    • Castañón Fernández, Christelle;
    • Mora, Elvira;
    • Gutiérrez, Lorena;
    • Rey Bua, Beatriz;
    • Jiménez Lorenzo, Maria José;
    • Díaz Beya, Marina;
    • Vara Pampliega, Miriam;
    • Molero, Antonieta;
    • Sánchez-García, Joaquín;
    • Calabuig, Marisa;
    • Cedena, Maria Teresa;
    • Chen-Liang, Tzu;
    • Díaz Santa, Johana Alejandra;
    • Padilla, Irene;
    • Hernández, Francisca;
    • Díez, Rosana;
    • Asensi, Pedro;
    • Xicoy, Blanca;
    • Sanz, Guillermo
    Publication type:
    Article
    39

    Diverse real-life outcomes after intensive risk-adapted therapy for 1034 AML patients from the CETLAM Group.

    Published in:
    Blood Cancer Journal, 2025, v. 15, n. 1, p. 1, doi. 10.1038/s41408-024-01205-5
    By:
    • Oñate, Guadalupe;
    • Garrido, Ana;
    • Arnan, Montserrat;
    • Pomares, Helena;
    • Alonso, Ester;
    • Tormo, Mar;
    • Diaz-Beya, Marina;
    • Vives, Susana;
    • Zamora, Lurdes;
    • Sampol, Antonia;
    • Coll, Rosa;
    • Salamero, Olga;
    • Cervera, Marta;
    • Garcia, Antoni;
    • Vall-Llovera, Ferran;
    • Garcia-Avila, Sara;
    • Bargay, Joan;
    • Ortin, Xavier;
    • Iranzo, Eva;
    • Guijarro, Francisca
    Publication type:
    Article
    40

    Outcomes of older adults undergoing allogeneic hematopoietic cell transplantation with post‐transplant cyclophosphamide based prophylaxis.

    Published in:
    European Journal of Haematology, 2024, v. 113, n. 6, p. 765, doi. 10.1111/ejh.14291
    By:
    • Murillo, Victoria;
    • Charry, Paola;
    • Suárez‐Lledó, María;
    • Guardia, Laia;
    • Moreno, Cristina;
    • Cid, Joan;
    • Lozano, Miquel;
    • Pedraza, Alexandra;
    • Salinas, Raquel;
    • Vilas, Vanessa;
    • Duch, Montserrat;
    • Díaz‐Beya, Marina;
    • Rosiñol, Laura;
    • Esteve, Jordi;
    • Carreras, Enric;
    • Fernández‐Avilés, Francesc;
    • Martínez, Carmen;
    • Rovira, Montserrat;
    • Salas, María Queralt
    Publication type:
    Article
    41